Pages that link to "Q72696680"

The following pages link to Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study (Q72696680):

Displaying 32 items.

• Liquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokinetics (Q28706344) (← links)
• Topoisomerase I-mediated DNA cleavage induced by the minor groove-directed binding of bibenzimidazoles to a distal site (Q33263160) (← links)
• Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity (Q33502564) (← links)
• Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates (Q33601744) (← links)
• Separation methods for camptothecin and related compounds. (Q34510160) (← links)
• The novel highly lipophilic topoisomerase I inhibitor DB67 is effective in the treatment of liver metastases of murine CT-26 colon carcinoma. (Q34928276) (← links)
• Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs (Q35026064) (← links)
• Anticancer Camptothecin-N-Poly(lactic acid) Nanoconjugates with Facile Hydrolysable Linker. (Q35628729) (← links)
• Fluorescence detection of the anticancer drug topotecan in plasma and whole blood by two-photon excitation. (Q36834670) (← links)
• Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle (Q37173162) (← links)
• Single-antibody, targeted nanoparticle delivery of camptothecin (Q37227392) (← links)
• Topoisomerase I inhibitors and drug resistance (Q40028536) (← links)
• High-Capacity Drug Carriers from Common Polymer Amphiphiles (Q42368167) (← links)
• Study of human serum albumin structure by dynamic light scattering: two types of reactions under different pH and interaction with physiologically active compounds (Q42538451) (← links)
• Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo (Q43698657) (← links)
• Synthesis and evaluation of a novel E-ring modified alpha-hydroxy keto ether analogue of camptothecin (Q43819219) (← links)
• OSI-211, a novel liposomal topoisomerase I inhibitor, is active in SCID mouse models of human AML and ALL. (Q44512464) (← links)
• Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignancies (Q46679638) (← links)
• Plasma and tissue disposition of non-liposomal DB-67 and liposomal DB-67 in C.B-17 SCID mice (Q46774695) (← links)
• Supramolecular host-inhibited excited-state proton transfer and fluorescence switching of the anti-cancer drug, topotecan (Q50230861) (← links)
• Binding Performance of Human Intravenous Immunoglobulin and 20()-7-Ethylcamptothecin (Q58691864) (← links)
• Topoisomerase I-targeting drugs (Q60710040) (← links)
• Camptothecin-binding site in human serum albumin and protein transformations induced by drug binding (Q62271232) (← links)
• The regio-selective synthesis of 10-hydroxy camptothecin norcantharidin conjugates and their biological activity evaluation in vitro. (Q64890853) (← links)
• The Important Role of Albumin in Determining the Relative Human Blood Stabilities of the Camptothecin Anticancer Drugs (Q71943656) (← links)
• The role of pH and serum albumin in the metabolic conversion of 9‐nitrocamptothecin to 9‐aminocamptothecin by human hematopoietic and other cells (Q72052170) (← links)
• Structure-activity relation in camptothecin antitumor drugs: why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies? (Q73219493) (← links)
• Spectroscopic Probes of the Individual and Combined Effects of Triton X‐100 and Chloroform on Serum Albumins and Serum‐Albumin · Bilirubin Complexes (Q73502628) (← links)
• In vitro binding and partitioning of irinotecan (CPT-11) and its metabolite, SN-38, in human blood (Q73831862) (← links)
• Liposomal delivery of camptothecins (Q73855624) (← links)
• Anti-tumor activity of CPT-11 in experimental human ovarian cancer and human soft-tissue sarcoma (Q73943052) (← links)
• Predicting plasma protein binding of drugs: a new approach (Q78408599) (← links)